{"id":790512,"date":"2024-11-25T16:03:27","date_gmt":"2024-11-25T21:03:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/"},"modified":"2024-11-25T16:03:27","modified_gmt":"2024-11-25T21:03:27","slug":"third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/","title":{"rendered":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO, Nov.  25, 2024  (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chris Murphy, Chief Financial and Business Officer, will participate in a fireside chat at the 7th Annual\u00a0Evercore\u00a0HealthCONx Conference\u00a0on Wednesday, December 4, 2024, at 9:35 a.m.<\/p>\n<p>A live audio webcast will be available within the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zsa2G48UHa_pjDW-Os27VD7UoZPTFDODh5p9KWUqakAmRuHZpQWzAU_z4cXXE7a-OpPQO2xxyhDxMf9PZdxXnHVrR11C4qz_et_c1145qTRCq4bxz71tn3vTjLms_2m--nQtZq6ysRrbX16Bk2d2XA==\" rel=\"nofollow\" target=\"_blank\">Investors &amp; Media<\/a>\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event.<\/p>\n<p>\n        <strong>About Third Harmonic Bio, Inc.<\/strong><br \/>\n        <br \/>Third Harmonic Bio is a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases through the development of novel, highly selective, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Early clinical studies demonstrate that KIT inhibition has the potential to revolutionize the treatment of a broad range of mast-cell-mediated inflammatory diseases, and that a titratable, oral small molecule inhibitor may provide the optimal therapeutic profile against this target. Third Harmonic Bio\u2019s lead product candidate, THB335, is a titratable, oral, small molecule inhibitor that is currently in a Phase 1 clinical trial. For more information, please visit the Third Harmonic Bio website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PaLSSZt2S2xnvitOHWGZ5wIfb1FQlPC-3qzMAGZWjZKGKrFOc117AM3Ss2DxxmdX54DAlc0aWKNxhe_tj7U81nXmVbMH_vYFrV2smzqvr8s=\" rel=\"nofollow\" target=\"_blank\">www.thirdharmonicbio.com<\/a><u>.<\/u><\/p>\n<p>\n        <strong>Investor and Media Contact:<\/strong><br \/>\n        <br \/>Lori Murray<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jMCi3XE5WAJcBXiDHhc1P_TUEwmpTBGx44yBfFEtnZ_pbus-YOr9tgKFnbjkxIF0nJvbOjvjka9mdjSPUp-JgqD82OHbZ-nR8jLvFA5k_AKVcDEvKXKUVtfh6RQUg9gL\" rel=\"nofollow\" target=\"_blank\">lori.murray@thirdharmonicbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjE2ZDYwOGEtYjcyNy00OTA5LTliNWEtYTdjMWYzMjJjZjEzLTEyNTgxMTk=\/tiny\/Third-Harmonic-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chris Murphy, Chief Financial and Business Officer, will participate in a fireside chat at the 7th Annual\u00a0Evercore\u00a0HealthCONx Conference\u00a0on Wednesday, December 4, 2024, at 9:35 a.m. A live audio webcast will be available within the\u00a0Investors &amp; Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases through the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-790512","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chris Murphy, Chief Financial and Business Officer, will participate in a fireside chat at the 7th Annual\u00a0Evercore\u00a0HealthCONx Conference\u00a0on Wednesday, December 4, 2024, at 9:35 a.m. A live audio webcast will be available within the\u00a0Investors &amp; Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases through the &hellip; Continue reading &quot;Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T21:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference\",\"datePublished\":\"2024-11-25T21:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/\"},\"wordCount\":243,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/\",\"name\":\"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\",\"datePublished\":\"2024-11-25T21:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/","og_locale":"en_US","og_type":"article","og_title":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk","og_description":"SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chris Murphy, Chief Financial and Business Officer, will participate in a fireside chat at the 7th Annual\u00a0Evercore\u00a0HealthCONx Conference\u00a0on Wednesday, December 4, 2024, at 9:35 a.m. A live audio webcast will be available within the\u00a0Investors &amp; Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases through the &hellip; Continue reading \"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-11-25T21:03:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference","datePublished":"2024-11-25T21:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/"},"wordCount":243,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/","name":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=","datePublished":"2024-11-25T21:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI4OTY5NiM2NjEwMTYyIzIyNDY1NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-7th-annual-evercore-healthconx-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=790512"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790512\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=790512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=790512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=790512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}